by Brooke Blazr | May 14, 2026 | High Dispatch
For years, the cannabis industry has treated federal rescheduling like a finish line. It isn’t. If cannabis moves to Schedule III, it’ll provide some tax benefits and open a new market pathway, but the result won’t be a unified, legitimate industry—it’ll be a split...
by Brooke Blazr | May 14, 2026 | High Dispatch
So, are cannabis pens gaining ground in North America? The overall trend says yes. However, a more insightful question is why they are becoming more popular and what this reveals about the future of legal cannabis.
by Brooke Blazr | May 13, 2026 | High Dispatch
This is the legacy knowledge drain, and it is the quiet catastrophe nobody in the cannabis industry wants to talk about openly—because acknowledging it means acknowledging that the “professionalization” of weed has, in many respects, destroyed the thing...
by Brooke Blazr | May 12, 2026 | High Dispatch
The petrochemical industry that grew in hemp’s absence now generates revenues in the tens of trillions annually across its downstream product chains—plastics, synthetic fibers, lubricants, paints, solvents, packaging, insulation, construction...
by Brooke Blazr | May 11, 2026 | High Dispatch
Every two years, cannabis advocates wheel out the same ritual. Ballot measures, candidate endorsements, grasstops lobbying, NORML scorecards, press releases about historic progress. Every two years, a version of the same headline runs: “Cannabis Reform Reaches...
by Brooke Blazr | May 11, 2026 | High Dispatch
In the rapidly evolving world of cannabis, information is the most valuable currency. For years, platforms like Cannabis.net have served as the ultimate hub for enthusiasts, patients, and industry professionals to stay informed about legalization, medical...
